SE419753B - Sett att framstella nya aualoger av deamino-vasopressin med modifierad disalfidbrygga - Google Patents

Sett att framstella nya aualoger av deamino-vasopressin med modifierad disalfidbrygga

Info

Publication number
SE419753B
SE419753B SE7411817A SE7411817A SE419753B SE 419753 B SE419753 B SE 419753B SE 7411817 A SE7411817 A SE 7411817A SE 7411817 A SE7411817 A SE 7411817A SE 419753 B SE419753 B SE 419753B
Authority
SE
Sweden
Prior art keywords
disalfid
aualogs
deamino
vase
bridge
Prior art date
Application number
SE7411817A
Other languages
English (en)
Swedish (sv)
Other versions
SE7411817L (ko
Inventor
Z Prochazka
T Barth
J H Cort
K Jost
F Sorm
Original Assignee
Ceskoslovenska Akademie Ved
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceskoslovenska Akademie Ved filed Critical Ceskoslovenska Akademie Ved
Publication of SE7411817L publication Critical patent/SE7411817L/xx
Publication of SE419753B publication Critical patent/SE419753B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7411817A 1973-11-09 1974-09-19 Sett att framstella nya aualoger av deamino-vasopressin med modifierad disalfidbrygga SE419753B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS7700A CS171787B1 (ko) 1973-11-09 1973-11-09

Publications (2)

Publication Number Publication Date
SE7411817L SE7411817L (ko) 1975-05-12
SE419753B true SE419753B (sv) 1981-08-24

Family

ID=5426587

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7411817A SE419753B (sv) 1973-11-09 1974-09-19 Sett att framstella nya aualoger av deamino-vasopressin med modifierad disalfidbrygga

Country Status (15)

Country Link
US (1) US3980631A (ko)
JP (1) JPS5411319B2 (ko)
AR (1) AR207765A1 (ko)
BE (1) BE822062A (ko)
CA (1) CA1020547A (ko)
CH (1) CH610879A5 (ko)
CS (1) CS171787B1 (ko)
DE (1) DE2452279A1 (ko)
DK (1) DK567474A (ko)
FR (1) FR2250751B1 (ko)
GB (1) GB1440859A (ko)
IN (1) IN140167B (ko)
IT (1) IT1056739B (ko)
NL (1) NL7414490A (ko)
SE (1) SE419753B (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235881A (en) * 1978-12-04 1980-11-25 Cort Joseph H Method for producing high potency factor VIII
US4285858A (en) * 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure
US4829051A (en) * 1983-04-05 1989-05-09 Vega Laboratories, Inc. N-substituted derivatives of 1-desaminovasopressin
US4483794A (en) * 1983-05-10 1984-11-20 Ceskoslovenska Akademie Ved Analogs of neurohypophysial hormones
US4551445A (en) * 1983-10-14 1985-11-05 The Medical College Of Ohio Derivatives of arginine vasopressin antagonists
US4714696A (en) * 1984-01-26 1987-12-22 Medical College Of Ohio Novel derivatives of arginine vasopressin antagonists
IE58407B1 (en) * 1984-04-13 1993-09-22 Akzo Nv Peptides
US4760052A (en) * 1986-01-16 1988-07-26 Smithkline Beckman Corporation 1,6-dicarba-vasopressin compounds
EP0300036A4 (en) * 1987-01-30 1989-06-14 Biomed Res Consultants Ltd PHARMACEUTICAL COMPOSITIONS BASED ON VASOPRESSIN.
US4786631A (en) * 1988-03-18 1988-11-22 University Of Florida Novel arginine vasopressin-binding peptides
US6028168A (en) 1991-08-09 2000-02-22 Winfried Kolbeck Lanthionine bridged peptides
AU2237095A (en) * 1994-04-01 1995-10-23 Arcturus Pharmaceutical Corporation Method for delivering biologically active materials using a thioester or thioether prodrug
US5562812A (en) * 1995-04-03 1996-10-08 The Penn State Research Foundation Free flow electrophoresis device for biomolecule purification and separation in zero and one G
US20100160214A1 (en) * 2008-12-22 2010-06-24 Serenity Pharmaceuticals Corporation Desmopressin composition
DK2381923T4 (da) 2008-12-22 2023-09-11 Acerus Pharmaceuticals Usa Llc Intranasal administration af desmopressin
PL3679941T3 (pl) 2009-06-18 2023-04-17 Serenity Pharmaceuticals Llc Bezpieczne podawanie desmopresyny

Also Published As

Publication number Publication date
CS171787B1 (ko) 1976-11-29
JPS5411319B2 (ko) 1979-05-14
DE2452279A1 (de) 1975-05-15
AR207765A1 (es) 1976-10-29
CA1020547A (en) 1977-11-08
BE822062A (fr) 1975-03-03
IT1056739B (it) 1982-02-20
FR2250751A1 (ko) 1975-06-06
JPS5088085A (ko) 1975-07-15
US3980631A (en) 1976-09-14
CH610879A5 (ko) 1979-05-15
GB1440859A (en) 1976-06-30
NL7414490A (nl) 1975-05-13
DK567474A (ko) 1975-07-07
SE7411817L (ko) 1975-05-12
IN140167B (ko) 1976-09-25
FR2250751B1 (ko) 1979-05-11

Similar Documents

Publication Publication Date Title
SE419753B (sv) Sett att framstella nya aualoger av deamino-vasopressin med modifierad disalfidbrygga
SE407522B (sv) Sett att reducera hallfastheten for is
SE417204B (sv) Sett att framstella nya kinoxalin- och kinazolinderivat
SE7614680L (sv) Sett att framstella nya bensodiazepinderivat
SE421615B (sv) Sett att framstella nya tiazolderivat
SE393126B (sv) Sett vid tillverkning av kub-pa-kant-orienterat kiselstal
SE7711848L (sv) Sett att framstella nya 5-metyl-7-hydroxi-isoflavonderivat
SE393383B (sv) Sett att framstella adenosinderivat
DK138467C (da) Kobling til fremstilling af af tegnsegmenter bestaaende tegn
SE410600B (sv) Sett att framstella nya arylaminopyrimidinderivat
SE7608643L (sv) Sett att framstella segmentpolymerisat
SE382215B (sv) Sett att framstella kromanderivat
FI55335C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 7-fluor-substituerade fenotiaziner
NO137750C (no) Fremgangsmaate til rensning av titantetraklorid
NO141094C (no) Anvendelse av blokk-kopolymerer for forbedring av klebeevnen til klebemidler
SE398349B (sv) Sett att framstella nya pyrimidinyl-6-acethydroxamsyror
SE399270B (sv) Sett att framstella spirolaktonsteroider
SE7606178L (sv) Sett att framstella nya cefalosporinderivat
SE397679B (sv) Sett att framstella kinazolinonderivat
FI52694C (fi) Venttiililaite, joka kykenee reagoimaan paine-eroihin
SE7509209L (sv) Sett att framstella nya kinolinderivat
SE419647B (sv) Sett att framstella tiazolisokinolinderivat
SE415252B (sv) Sett att framstella nya oxifenylbutazonderivat
SE413022B (sv) Sett att framstella nya propylendiaminderivat
SE396608B (sv) Sett att framstella nya penicilliner